Sequent Scientific is currently trading at Rs. 386.00, up by 0.95 points or 0.25% from its previous closing of Rs. 385.05 on the BSE.
The scrip opened at Rs. 377.65 and has touched a high and low of Rs. 389.95 and Rs. 377.65 respectively. So far 4981 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 406.00 on 02-Jul-2014 and a 52 week low of Rs. 81.30 on 31-Jul-2013.
Last one week high and low of the scrip stood at Rs. 403.50 and Rs. 345.00 respectively. The current market cap of the company is Rs. 1052.40 crore.
The promoters holding in the company stood at 65.35% while Institutions and Non-Institutions held 0.15% and 34.50% respectively.
Morgan Stanley Asia (Singapore) has bought 2.51 lakh shares of Sequent Scientific through open market route. The shares were purchased on an average price of Rs 375 valuing the transaction to Rs 9.42 crore. On the other hand, Satpal Khattar has sold 2.57 lakh shares of the company for an average price of Rs 375.04 through open market route.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
